Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy

Heart

Volumn 92, Issue 12, 2006, Pages 1760-1763

  Van Der Schaaf, R J ^a   Timmer, J R ^a   Ottervanger, J P ^a   Hoorntje, J C A ^a   De Boer, M J ^a   Suryapranata, H ^a   Zijlstra, F ^b   Dambrink, Jan Henk E ^a  

^a ISALA HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; MULTIVARIATE ANALYSIS; MULTIVESSEL CORONARY ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION;

FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; THROMBOLYTIC THERAPY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33750043034     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.086058     Document Type: Article

References (22)

1. White HD, Norris RM, Brown MA, et al. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med 1987;317:850-5.
2. De Boer MJ, Suryapranata H, Hoorntje JCA, et al. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation 1994;90:753-61.
3. Weintraub WS, King SB 3rd, Douglas JS Jr, et al. P. rcutaneous transluminal angioplasty as a first revascularization procedure in single-, double- and triple-vessel coronary artery disease. J Am Coll Cardiol 1995;26:142-51.
4. Zijlstra F, de Boer MJ, Beukema WP, et al. Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction. Eur Heart J 1996;17:382-7.
5. Arnold AE, Simoons ML, Detry JM, et al. Prediction of mortality following hospital discharge after thrombolysis for acute myocardial infarction: is there a need for coronary angiography? Eur Heart J 1993;14:306-15.
6. Muller DW, Topol EJ, Ellis SG, and the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group, et al. Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Am Heart J 1991;121:1042-9.
7. Kahn JK, Rutherford BD, McConahay DR, et al. Results of primary angioplasty for acute myocardial infarction in patients with multivessel coronary artery disease. J Am Coll Cardiol 1990;16:1089-96.
8. O'Keefe JH Jr, Rutherford BD, McConahay DR, et al. Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1989;64:1221-30.
9. Vacek J, Rosamond TL, Robuck W, et al. Prognosis of culprit lesion PTCA in acute myocardial infarction for multi versus single vessel disease. Cathet Cardiovasc Diagn 1991;24:161-5.
10. Zijlstra F, Hoorntje JCA, de Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999;341:1413-9.
11. Zijlstra F, de Boer MJ, Hoorntje JCA, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4.
12. Madsen JK, Grande P, Saunamaki K, et al. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction. Circulation 1997;96:748-55.
13. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation 1982;65:457-64.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
15. Cox DR. Regression models and life-tables. J R Stat Soc 1972;34:187-220.
16. Hannan EL, Racz MJ, Arani DT, et al. Short- and long-term mortality for patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2000;36:1194-201.
17. Shihara M, Tsutsui H, Tsuchihashi M, et al. In-hospital and one-year outcomes for patients undergoing percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2002;90:932-6.
18. Schultz R, Heusch G. Hibernating myocardium. Heart 2000;84:587-94.
19. Ottervanger JP, van 't Hof AWJ, Reifgers S, et al. Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J 2001;22:785-90.
20. Van Domburg RT, Foley DP, de Feyter PJ, et al. Long-term clinical outcome after coronary balloon angioplasty: identification of a population at low risk of recurrent events during 17 years of follow-up. Eur Heart J 2001;22:891-3.
21. Suryapranata H, van 't Hof AWJ, Hoorntje JCA, et al. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998;97:2502-5.
22. Neumann FJ, Blasini R, Schmitt C, et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation 1998;98:2695-701.